Overview

Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema.

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
To review the safety and efficacy of injections with Ozurdex (700 μg dexamethasone) in clinical practice management of patients with DME.
Details
Lead Sponsor:
Association for Innovation and Biomedical Research on Light and Image
Collaborator:
European Vision Institute Clinical Research Network
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate